Stockscreener 앱 받기
3.80
3.31%
-0.1299
시간 외 거래:
3.90
0.10
+2.63%
전일 마감가:
$3.9299
열려 있는:
$3.81
하루 거래량:
11,824
Relative Volume:
0.67
시가총액:
$7.91M
수익:
$5.27M
순이익/손실:
$-7.98M
주가수익비율:
-5.3604
EPS:
-0.7089
순현금흐름:
$-7.04M
1주 성능:
+1.07%
1개월 성능:
-17.03%
6개월 성능:
-6.03%
1년 성능:
+653.97%
1일 변동 폭
$3.5878
$3.9399
1주일 범위
$3.56
$3.9399
52주 변동 폭
$0.4512
$4.73
Neurometrix Inc Stock (NURO) Company Profile
명칭
Neurometrix Inc
전화
(781) 890-9989
주소
1000 WINTER STREET, WALTHAM
NURO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| NURO | 3.80 | 7.91M | 5.27M | -7.98M | -7.04M | -0.7089 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-10-20 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2015-09-11 | 개시 | Maxim Group | Buy |
| 2012-02-27 | 개시 | Dawson James | Buy |
Neurometrix Inc 주식(NURO)의 최신 뉴스
NeuroMetrix revenue down 51% in Q3 2024 - Medical Buyer
NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth - MSN
NeuroMetrix revenue increases 50% to USD 184,000 in Q3 2024 - Medical Buyer
NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023) - Yahoo Finance
NeuroMetrix Q3 2024: Mixed Results Amid Strategic Review - TipRanks
NeuroMetrix Reports Q3 2024 Business Highlights - The Manila Times
NeuroMetrix Q3 Revenue Falls 51% Despite Quell Growth; Cost-Cutting Efforts Show Promise | NURO Stock News - StockTitan
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
NeuroMetrix stock touches 52-week high at $4.73 - Investing.com India
NeuroMetrix stock touches 52-week high at $4.73 By Investing.com - Investing.com UK
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Neuromuscular Electrical Muscle Stimulator Industry likely to thriving future growth - Elektrotransports.lv
Transcutaneous Electrical Nerve Muscle Stimulation Industry Size, Status and Business Outlook - Elektrotransports.lv
Interferential Muscle Stimulator Industry Report By Type, Application and Geography - Elektrotransports.lv
Diabetic Neuropathy Market May See a Big Move | Cephalon, GlaxoSmithKline, NeuroMetrix - openPR
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
Financial Analysis: NeuroMetrix (NASDAQ:NURO) versus Sensus Healthcare (NASDAQ:SRTS) - Defense World
NeuroMetrix Inc. | RapidScan | Dec 2006 - Photonics.com
Muscle Stimulator Market Size, Share, Growth Insights - openPR
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World
Internal Neuromodulation Devices Market Size, Trends And Forecast 2024-2033 - WhaTech
One Point One Solutions shares gain as company expands healthcare verticalCheck details - MSN
Rhumbline Advisers Grows Stake in Neumora Therapeutics, Inc. (NASDAQ:NMRA) - Defense World
Kalikesh Singh wins NRAI President election; onus on him to take shooting to next level - RevSportz
Kalikesh Narayan Singh Deo elected NRAI President - IndianShooting.com
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo
Mobile-health Network Solutions Receives Nasdaq Delinquency Notice for Minimum Bid Price Requirement - Vancity Buzz
High ROE & high ROCE multibagger stock in focus as company bags pilot export orders worth Rs 2,40,00,000 from clients in Europe, Middle East and USA - Dalal Street Investment Journal
A phone camera as health screening device? Healthtech agency’s new home displays innovations - The Straits Times
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by State of New Jersey Common Pension Fund D - Defense World
Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - GlobeNewswire Inc.
Exploring Opportunities in the Muscle Stimulation Devices - openPR
Muscle Stimulator Market Statistical Forecast, Trade Analysis - openPR
NeuroMetrix (STU:NLZ0) Shares Outstanding (EOP) : 2.02 Mil (As of Jun. 2024) - GuruFocus.com
NeuroMetrix (NASDAQ:NURO) Receives New Coverage from Analysts at StockNews.com - Defense World
NeuroMetrix continues strategic review to boost value - Investing.com India
NeuroMetrix stock plunges to 52-week low of $2.66 By Investing.com - Investing.com Canada
NeuroMetrix Reiterates its Review of Strategic Alternatives - StockTitan
NeuroMetrix stock plunges to 52-week low of $2.66 - Investing.com
NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023) - Yahoo Finance
Smart Medical Devices Market SWOT and PESTAL Analysis | 2032 - WICZ
Muscle Stimulation Devices Market Detailed Size Estimates - openPR
NURO Stock Earnings: NeuroMetrix Reported Results for Q2 2024 - MSN
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options - StockTitan
NeuroMetrix reports Q2 revenue $769,148 vs. $1.66M last year - TipRanks
NeuroMetrix (NURO) Scheduled to Post Earnings on Tuesday - Defense World
Neurostimulation Devices Market size is set to grow by USD 6.26 billion from 2023-2027, Rising prevalence of neurological disorders to boost the market growth, Technavio - The Malaysian Reserve
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - ForexTV.com
Smart Medical Devices Market Size to Surpass $65.45 Billion by 2032 - The NRI News
Neurometrix Inc (NURO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.43%
자본화:
|
볼륨(24시간):